Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study

KAYA, Mehmet; ÖZKAN, METİN; Gunebakmaz, Özgür; Akkaya, Hasan; Kaya, Esma; Akpek, Mahmut; KALAY, NİHAT; Dikilitas, Mustafa; Yarlioglues, Mikail; Karaca, Halit; Berk, Veli; Ardic, Idris; Ergin, ALİ; Lam, Yat

doi:10.1016/j.ijcard.2012.06.023

Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study

Atıf İçin Kopyala

KAYA M. F., ÖZKAN M., Gunebakmaz O., Akkaya H., Kaya E. G., Akpek M., ...Daha Fazla

INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.167, sa.5, ss.2306-2310, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 167 Sayı: 5
Basım Tarihi: 2013
Doi Numarası: 10.1016/j.ijcard.2012.06.023
Dergi Adı: INTERNATIONAL JOURNAL OF CARDIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2306-2310
Anahtar Kelimeler: Nebivolol, Anthracycline, Cardiomyopathy, DOXORUBICIN-INDUCED CARDIOMYOPATHY, METASTATIC BREAST-CANCER, 5-FLUOROURACIL CARDIOTOXICITY, RECEPTOR BLOCKER, HEART-FAILURE, NITRIC-OXIDE, CARVEDILOL, CHEMOTHERAPY, TRIAL, RATS
Erciyes Üniversitesi Adresli: Evet

Özet

Background: We aimed to evaluate the effect of prophylactic nebivolol use on prevention of antracycline-induced cardiotoxicity in breast cancer patients.